Category Archives: Dapagliflozin

FDA Delays Final OK for Type 2 Drug Empagliflozin

The FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until “previously observed deficiencies” at the plant where it is manufactured are fixed.

The delay does not call into question the safety or utility of …

Dapagliflozin Teams Well With Metformin, Sulfonylurea

According to researchers, dapagliflozin, a diabetes drug developed jointly by two pharmaceutical companies has shown significant benefits when teamed with metformin and sulfonylurea.

The drug, already available in Europe, is produced by Bristol-Myers and AstraZeneca. It has been shown to …

Type 2 Drugs in the Pipeline: an Update

If you Google “type 2 diabetes drugs,” one website lists the names of 92 drugs that medical professionals have prescribed at one time or another to treat diabetes.

You’d think that the diabetes apothecary has a more than a sufficient …